Management of Abdominal Aortic Aneurysms in 2021

Abdominal aortic aneurysms (AAA) are those of >3 cm aortic diameter.  They run the risk of rupture and ensuing death by bleeding. In consequence, they are treated to repair the aneurysm before it ruptures. 

Manejo de los aneurismas de aorta abdominal en 2021

In this regard, the most relevant predictor of rupture is aneurysm diameter. That is, the greater the aneurysm, the greater the risk. 

Randomized studies have not shown advantages in survival when <5.5 cm aneurysms were surgically treated vs. close observation. This evidence supports the use of 5.5 cm diameter as a cutoff value. Therefore, watching <5.5 cm aneurysms closely is safe and cost effective. 

Close observation, among other things, will detect aneurysms that might present accelerated sac growth (>1 cm in one year), even though we lack rigorous information to support intervention in this context. 

The key clinical points for AAA management in 2021 are:

  • Risk factors include advanced age, male sex, family history, smoking, hypercholesterolemia, and hypertension. Diabetics run the lowest risk. 
  • In men, AAA should be repaired when they are ≥5.5 cm diameter, and in women, when they are ≥5 cm.
  • Endovascular repair of AAA is associated with lower risk of perioperative complications and death vs. open surgery. 
  • The initial advantage of endovascular repair is kept for 2 or 3 years after procedure. There are no differences at long term in terms of death. 
  • Endovascular repair is associated to more reinterventions, in general simple procedures. Throughout patient life, open surgery is associated to more reinterventions due to laparotomy. 
  • For close observation, both CT and echocardiography are adequate.

Read also: TCT 2021 | STOPDAPT-2 and MASTER-DAPT: The Conversation Continues from ESC to TCT.


This is the most succinct information, and it is not much different from what have known for some time. Data are reassuring, seeing as they indicate we understand this disease, and thus we can take preventive action. 

nejmcp2108504

Original Title: Management of Abdominal Aortic Aneurysms.

Reference: Andres Schanzer et al. N Engl J Med 2021;385:1690-8. DOI: 10.1056/NEJMcp2108504.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...